Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
CNS Spectrums|September 21, 2013
Pharmacogenetics of mood disorders: what clinicians need to knowGonzalo LajeProgress in Neuro-Psychopharmacology & Biological Psychiatry|December 1, 2010
Genome-wide association studies of antidepressant outcome: a brief reviewGonzalo Laje, Francis J McMahonPharmacogenetics and Genomics|February 14, 2009
Association study of phosphodiesterase genes in the Sequenced Treatment Alternatives to Relieve Depression sampleMichael Cabanero, Gonzalo Laje, Sevilla Detera-Wadleigh, et al.Archives of General Psychiatry|June 7, 2006
National trends in the outpatient treatment of children and adolescents with antipsychotic drugsMark Olfson, Carlos Blanco, Linxu Liu, et al.JAMA Psychiatry|November 29, 2013
National trends in the mental health care of children, adolescents, and adults by office-based physiciansMark Olfson, Carlos Blanco, Shuai Wang, et al.JAMA Network Open|April 28, 2023
Treatment of US Children With Attention-Deficit/Hyperactivity Disorder in the Adolescent Brain Cognitive Development StudyMark Olfson, Melanie M Wall, Shuai Wang, et al.Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorderJessica A Cutler, A John Rush, Francis J McMahon, et al.Psychiatric Services (Washington, D.C.)|November 3, 2009
Pharmacogenetics studies in STAR*D: strengths, limitations, and resultsGonzalo Laje, Roy H Perlis, A John Rush, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 29, 2010
Pharmacological treatment of disruptive behavior in Smith-Magenis syndromeGonzalo Laje, Rebecca Bernert, Rebecca Morse, et al.The American Journal of Psychiatry|June 4, 2002
Trends in the treatment of bipolar disorder by outpatient psychiatristsCarlos Blanco, Gonzalo Laje, Mark Olfson, et al.Pageof 6